购物车
您的购物车当前为空
STAT3-IN-41 (Compound 16) 是 compound 1 的前药,能够缓慢释放抑制STAT3信号通路的 compound 1,并对肺癌、肝细胞癌和胰腺癌显示出抗肿瘤活性。

STAT3-IN-41 (Compound 16) 是 compound 1 的前药,能够缓慢释放抑制STAT3信号通路的 compound 1,并对肺癌、肝细胞癌和胰腺癌显示出抗肿瘤活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
| 产品描述 | STAT3-IN-41 (Compound 16) is a prodrug of compound 1. It gradually releases compound 1, which inhibits the STAT3 signaling pathway. STAT3-IN-41 exhibits antitumor activity against lung cancer, hepatocellular carcinoma, and pancreatic cancer. |
| 分子量 | 477.471 |
| 分子式 | C22H30F3NO7 |
| Smiles | C[C@@]12CC/C=C(\CC[C@@H]3[C@@H]([C@@H]1O2)OC(=O)C3CN(C)C)/CC(F)(F)F.C(=C/C(=O)O)\C(=O)O |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多